Biosimilars, Clinical Supply and Therapies

Search:

DAY

WEEK

MONTH

YEAR

Select your country:
Sign up | Log in

Biosimilars

Clinical Supply

Therapies

Rapid delivery of toxicological material

Drug Target Review

SEPTEMBER 10, 2024

However, information would be required on whether the nominated formulation would be sufficiently stable to support the rapid formulation approach and subsequent comparison to the clinical supply. Therefore, there would be almost no appetite for trying to justify a change in formulation between Tox and clinical supplies.

Drug Development

Drug Development Clinical Supply Production Protein Expression

Molecular Partners Announces Collaboration With Novartis to Develop Two DARPin(R) Therapies Designed for Potential Use Against COVID-19

The Pharma Data

OCTOBER 27, 2020

During the clinical development stage, Molecular Partners will provide clinical supply. The companies will work together to scale-up manufacturing capacity, in collaboration with Sandoz, the generics and biosimilar Novartis division, to provide worldwide supply.

Therapies

Therapies Virus Treatment Clinical Trials

Drug Discovery Digest

Rapid delivery of toxicological material

Molecular Partners Announces Collaboration With Novartis to Develop Two DARPin(R) Therapies Designed for Potential Use Against COVID-19

Stay Connected